Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学DNA Methylation, Epigenetic Aging in Cancer

Jean-Pierre Issa

MD

🏢Lewis Katz School of Medicine at Temple University🌐USA

Director, Fels Institute for Cancer Research

80
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Jean-Pierre Issa is a pioneering epigeneticist whose work on DNA methylation in cancer has transformed understanding of epigenetic silencing in tumor suppressor gene inactivation. He was among the first to demonstrate that DNMT inhibitors can reverse aberrant DNA methylation and restore gene expression in cancer cells. His clinical research established low-dose hypomethylating agents as effective therapy for myelodysplastic syndrome and AML. He developed the epigenetic aging framework and continues to advance epigenetic therapy combinations.

Share:

🧪Research Fields 研究领域

DNA methylation cancer
epigenetic clock cancer
CpG island methylation
DNMT inhibitor clinical trials
AML epigenetics

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-03-01 | All information from publicly available academic sources

关注 Jean-Pierre Issa 的研究动态

Follow Jean-Pierre Issa's research updates

留下邮箱,当我们发布与 Jean-Pierre Issa(Lewis Katz School of Medicine at Temple University)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment